Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::78433e78b5dd0b95828f913851533503&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

EGFR Peptides as Vaccines in Anti-Tumor Immunity

assignment_turned_inproject30 Sep 2007(Started)-31 Mar 2009(Ended)Closed

Funder: National Institutes of HealthProject code: 1R41CA128165-01A1

Funded under: NATIONAL CANCER INSTITUTE Funder Contribution: 277,711 USD

EGFR Peptides as Vaccines in Anti-Tumor Immunity

- Summary
- DMPs

Partners

L2 DIAGNOSTICS, LLC

Data Management Plans

Start a new DMP in Argos

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::78433e78b5dd0b95828f913851533503&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

EGFR Peptides as Vaccines in Anti-Tumor Immunity

EGFR Peptides as Vaccines in Anti-Tumor Immunity

Loading